Studies have shown that CCL3 is central in the promotion and migration of inflammatory components to tissues in other autoimmune diseases, particularly rheumatoid arthritis, where it participates in the pathogenesis of cartilage bone destruction [14, 30]. Here, CCL3 is linked to autoimmune disease.